LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical and biotechnology industries, today announced ...
Simulations Plus, Inc. SLP recently rolled out the StrategiesPlus COVID-19 ACT Program to aid researchers in their fight against the global coronavirus pandemic. Offerings of the integrated program ...
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, recently invested ...